Mutation in Causes Hypomyelinating Leukodystrophy and Abnormal Ribosomal RNA Regulation
Overview
Authors
Affiliations
Objective: To identify the genetic cause of hypomyelinating leukodystrophy in 2 consanguineous families.
Methods: Homozygosity mapping combined with whole-exome sequencing of consanguineous families was performed. Mutation consequences were determined by studying the structural change of the protein and by the RNA analysis of patients' fibroblasts.
Results: We identified a biallelic mutation in a gene coding for a Pol III-specific subunit, (c.121C>T/p.Arg41Trp), that cosegregates with the disease in 2 unrelated patients. Patients expressed neurologic and extraneurologic signs found in - and -related leukodystrophies with a peculiar severe digestive dysfunction. The mutation impaired the POLR3K-POLR3B interactions resulting in zebrafish in abnormal gut development. Functional studies in the 2 patients' fibroblasts revealed a severe decrease (60%-80%) in the expression of 5S and 7S ribosomal RNAs in comparison with control.
Conclusions: These analyses underlined the key role of ribosomal RNA regulation in the development and maintenance of the white matter and the cerebellum as already reported for diseases related to genes involved in transfer RNA or translation initiation factors.
Abdel-Hamid M, Paimboeuf A, Zaki M, Figueiredo F, Abdel-Ghafar S, Maher S Brain Commun. 2025; 7(1):fcaf055.
PMID: 40040844 PMC: 11878552. DOI: 10.1093/braincomms/fcaf055.
Molecular basis of neurodegeneration in a mouse model of -related disease.
Moir R, Merheb E, Chitu V, Stanley E, Willis I Elife. 2024; 13.
PMID: 39499645 PMC: 11537486. DOI: 10.7554/eLife.95314.
Kraoua I, Jamoussi M, Drissi C, Kraoua L, Drunat S, Benrhouma H Mol Genet Genomic Med. 2024; 12(10):e70007.
PMID: 39436788 PMC: 11495397. DOI: 10.1002/mgg3.70007.
Lentini L, Toutounchi H, Chapleau A, Le A, Fournier S, Emari F J Child Neurol. 2024; 40(1):26-38.
PMID: 39429022 PMC: 11590388. DOI: 10.1177/08830738241283171.
Towards a Treatment for Leukodystrophy Using Cell-Based Interception and Precision Medicine.
Coulombe B, Chapleau A, Macintosh J, Durcan T, Poitras C, Moursli Y Biomolecules. 2024; 14(7).
PMID: 39062571 PMC: 11274857. DOI: 10.3390/biom14070857.